Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA …

M Van de Vijver, R Van de Bersselaar… - … and cellular biology, 1987 - Am Soc Microbiol
M Van de Vijver, R Van de Bersselaar, P Devilee, C Cornelisse, J Peterse, R Nusse
Molecular and cellular biology, 1987Am Soc Microbiol
We investigated alterations in the structure and expression of oncogenes in mammary
tumors and mammary tumor-derived cell lines. In 16 of 95 samples, we detected
amplification of the human neu oncogene, also known as c-erB-2, accompanied by
overexpression in the tumors from which intact RNA could be isolated. In 10 of these DNAs,
the linked oncogene c-erbA was also amplified, whereas another gene on human
chromosome 17, p53, was present in normal copy numbers. Overexpression of c-erbA could …
Abstract
We investigated alterations in the structure and expression of oncogenes in mammary tumors and mammary tumor-derived cell lines. In 16 of 95 samples, we detected amplification of the human neu oncogene, also known as c-erB-2, accompanied by overexpression in the tumors from which intact RNA could be isolated. In 10 of these DNAs, the linked oncogene c-erbA was also amplified, whereas another gene on human chromosome 17, p53, was present in normal copy numbers. Overexpression of c-erbA could not be detected in the tumors analyzed. The relatively high frequency of neu amplification points to a functional role in human breast cancer. Coamplification of the c-erbA oncogene could contribute to this disease as well but is most likely fortuitous.
American Society for Microbiology